JUSTIN BEEBE: Open Payments
NPI 1285128314 · OSWEGO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$851 in 44 payments from 11 companies in 2025. Trend: 2023 $1,672 · 2024 $1,270 · 2025 $851
Food & beverage: $851
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $267 |
| GlaxoSmithKline, LLC. | 6 | $106 |
| Abbott Laboratories | 4 | $81 |
| AstraZeneca Pharmaceuticals LP | 5 | $77 |
| Phathom Pharmaceuticals, Inc. | 3 | $67 |
| Lilly USA, LLC | 3 | $62 |
| Novo Nordisk Inc | 3 | $58 |
| Exact Sciences Corporation | 2 | $47 |
| Insulet Corporation | 1 | $32 |
| Amgen Inc. | 2 | $31 |
Products named: VRAYLAR, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, VOQUEZNA, JARDIANCE, QULIPTA, The Cologuard Plus Collection Kit, Ozempic.
Industry payments across NY — which companies pay providers there.
